Cancer research has played a pivotal role in improving patient outcomes. However, despite
the significant investment in fundamental cancer research over the past few decades, the …

Aim This narrative review aims to describe colorectal cancer (CRC) management landscape
in low-and middle-income countries (LMICs), presenting the most recent and relevant …

Objective: Compound Kushen injection (CKI), one of the commonly used antitumor Chinese
patent medicines, has been widely prescribed as adjunctive treatment to platinum-based …

We performed a systematic review and meta-analysis to assess the efficacy of EGFR-
tyrosine kinase inhibitors (TKI) retreatment in advanced/metastatic non-small-cell lung …

Background: Despite recent advances in targeted therapy and immunotherapy for advanced
non–small cell lung cancer (NSCLC), carboplatin/pemetrexed/bevacizumab remains a …

Background A mapping review of real-world evidence (RWE) publications on targeted
therapy (TT) for solid tumours was carried out to describe their characteristics, strengths, and …

The article explores on the clinicopathologic study of invasive apocrine carcinoma (IAC) of
the breast. It highlights the poor prognosis of IAC in patients with breast cancer. It also cites …

Background: Compound Kushen injection (CKI) is a commonly used anti-tumor Chinese
patent medicine, which is extracted from Kushen (Radix Sophorae Flavescentis) and …

Background Despite the advances in the management of advanced non–small cell lung
cancer (NSCLC), the access to genetic profiling and target therapies remains a challenge in …

The prevalence of cancer continues to rise, with a reported 23.6 million new cases
worldwide in 2019 alone. 1 In Central and Eastern Europe, prostate cancer composed 8.5 …